LUCD logo

LUCD
Lucid Diagnostics Inc

1,877
Mkt Cap
$209.16M
Volume
772,353.00
52W High
$1.63
52W Low
$0.90
PE Ratio
-2.20
LUCD Fundamentals
Price
$1.03
Prev Close
$1.05
Open
$1.05
50D MA
$1.12
Beta
0.73
Avg. Volume
857,068.84
EPS (Annual)
-$0.6922
P/B
-27.69
Rev/Employee
$57,390.24
$156.51
Loading...
Loading...

About

Lucid Diagnostics, Inc. is a commercial-stage medical diagnostics technology company. It focuses on patients with gastroesophageal reflux disease also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. The company was founded by Lishan Aklog on May 8, 2018 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
82

Frequently Asked Questions

What is Market Cap of Lucid Diagnostics Inc?
What is the 52-week high for Lucid Diagnostics Inc?
What is the 52-week low for Lucid Diagnostics Inc?
What is Lucid Diagnostics Inc stock price today?
What was Lucid Diagnostics Inc stock price yesterday?
What is the PE ratio of Lucid Diagnostics Inc?
What is the Price-to-Book ratio of Lucid Diagnostics Inc?
What is the 50-day moving average of Lucid Diagnostics Inc?
How many employees does Lucid Diagnostics Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available